BioCentury
ARTICLE | Company News

Onyvax, Cancer Research Campaign Technology Ltd. deal

May 17, 1999 7:00 AM UTC

Onyvax received an exclusive worldwide license from Cancer Research Campaign Technology (CRCT) to a cancer vaccine based on an antibody that mimics decay accelerating factor, a naturally occurring mol...